1.The effects of surgical stress and naloxone(NAL) on the concentration of plasma prolactin(PRL) and luteinizing hormone(LH).
Soon Chul HWANG ; Suk Hyun PARK ; Kyung Eon SONG ; Yoon Jung RHA ; Wang Soo KIM ; Chang Hoon SONG ; Seung Jin OH ; Sei Joon HAN
Korean Journal of Obstetrics and Gynecology 1992;35(8):1136-1143
2.A case of fetal cystic hygroma combined with maternal bilateral lutein cyst.
Sang Sik LEE ; Yeon Hee JANG ; Seung Ho HONG ; Sun Bo HWANG ; Moon Hwan IM ; Jae Cheol SIM ; Yong Tak KIM ; Sung Suk KIM ; Yeon Hee OHO ; Hyun Kyung LEE ; Hyeo Won YOON
Korean Journal of Perinatology 1993;4(4):571-577
No abstract available.
Lutein*
;
Lymphangioma, Cystic*
3.Response to comment on “Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene”.
The Korean Journal of Internal Medicine 2017;32(3):568-568
No abstract available.
Hypogonadism*
;
Lutein*
;
Luteinizing Hormone*
4.Comment on “Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene”.
Hernan VALDES-SOCIN ; Adrian F DALY ; Albert BECKERS
The Korean Journal of Internal Medicine 2017;32(3):566-567
No abstract available.
Hypogonadism*
;
Lutein*
;
Luteinizing Hormone*
5.Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene.
Jae Won SONG ; Hyo Jeong HWANG ; Chang Min LEE ; Gun Ha PARK ; Chul Sik KIM ; Seong Jin LEE ; Sung Hee IHM
The Korean Journal of Internal Medicine 2018;33(3):638-641
No abstract available.
Hypogonadism*
;
Lutein*
;
Luteinizing Hormone*
6.A randomized controlled trial on the effect of Lutein Supplementation on Macular Pigment Optical Density and Macular Function in Pseudophakic Patients
Victor Ephraime V. Paulino ; Edward C. Uy ; Sherman O. Valero
Philippine Journal of Ophthalmology 2021;46(2):88-95
Objective:
To evaluate the efficacy of oral lutein supplementation on macular pigment optical density (MPOD)
levels and macular function in pseudophakic eyes that underwent phacoemulsification.
Methods:
This was a prospective, randomized, parallel-arm, single-masked study comparing oral lutein supplement
20 mg/tablet (Lutax 20) with non-supplementation in pseudophakic eyes. We assessed MPOD, low-luminance
deficit (LLD), visual recovery time (VRT) using photostress test, and adverse events. One hundred twenty-eight
(128) eyes were enrolled and randomized 1:1 to active treatment (lutein supplementation) or no treatment (no
supplementation). The supplementation period was 12 weeks and patients were assessed every 4 weeks over a
period of 16 weeks.
Results:
Sixty-four (64) eyes in each group completed the study. A significant increase in MPOD (p<0.001) was
observed in the lutein supplemented group, from 0.36 DU at baseline to 0.55 DU at week 12, with a mean increase
of 6.32 ± 1.72% per 4 weeks of supplementation compared with a mean MPOD decrease rate of 0.63 ± 0.48%
in the non-supplementation group. A significant reduction in LLD was observed in the lutein-treated group, from
LogMAR 0.063 at baseline to LogMAR 0.023 at Week 12 (p=0.003). VRT was also significantly shorter in the
treatment from a baseline of 83.06 to 68.80 seconds at Week 12 (p<0.001).
Conclusion
Lutein supplementation (20 mg/tablet; Lutax 20) demonstrated a significant degree of MPOD
augmentation, and reductions in LLD and VRT among patients who underwent phacoemulsification with lens
implantation.
Lutein
;
Dietary Supplements
7.A case of idiopathic precocious puberty treated with a luteinizing hormone relaeasing hormone analog.
Keun Hee CHUNG ; Yoo Mi KIM ; Mi Won KIM ; Soon Ki KIM ; Moon Soo PARK ; Jin Keun CHANG
Journal of the Korean Pediatric Society 1991;34(8):1132-1138
No abstract available.
Lutein*
;
Luteinizing Hormone*
;
Puberty, Precocious*
8.The Changes of Serum Prostate-specific Antigen after Ejaculation.
Ju Hyun LIM ; Sang Deuk KIM ; Kyung Soo CHOI ; Seong Beom CHOI ; Dae Woong KIM ; Jong Kwan PARK
Korean Journal of Urology 2007;48(12):1247-1250
PURPOSE: Prostatic manipulation and surgery have been shown to increase serum prostate-specific antigen (PSA). We studied the effect of ejaculation on the serum PSA levels. MATERIALS AND METHODS: We evaluated 131 men(16 to 64 years old) who had no history of surgery or inflammatory disease of the urogenital tract. The total serum PSA, free PSA, serum total testosterone, free testosterone, luteinizing hormone(LH), and follicular stimulating hormone(FSH) were evaluated 1 hour after ejaculation. RESULTS: A PSA level was detected in all the men. There were statistically significant changes of the serum PSA level before and after ejaculation. We compared the parameters between increased PSA group and the decreased PSA group. There were significant differences between the two groups on comparison of the total prostate volume(25.4+/-3.6g vs 15.1+/-4.2g, respectively) and the transition zone volume(7.1+/-2.7g vs 5.3+/-1.1g, respectively). CONCLUSIONS: Based on our data, ejaculation affects the serum PSA concentration in young men, and there seems to be a physiological relationship between ejaculation and the PSA level. The larger the prostate volume, the more ejaculation has an effect on the serum PSA level.
Ejaculation*
;
Humans
;
Lutein
;
Male
;
Prostate
;
Prostate-Specific Antigen*
;
Testosterone
9.A case of ovarian sclerosing stromal tumor with massive ascites and elevated CA 125.
Hae Chang LEE ; Byoung Ryun KIM ; Jun Seok LEE ; Beob In LIM ; Heung Gon KIM ; Hyung Bae MOON ; Hoon Young KIM
Korean Journal of Obstetrics and Gynecology 2009;52(1):120-124
Sclerosing stromal tumor (SST) is an uncommon benign tumor of the ovary, representing 2~6% of all stromal ovarian tumors. It is a distinct benign neoplasm that differs from fibromas, thecomas, luteinized tumors and steroid cell tumors. It presents most often with non-specific symptoms and tumor markers usually remain normal. However massive ascites is a rare symptom. We report a case of sclerosing stromal tumor with massive ascites and elevated CA 125 with brief review of literature.
Ascites
;
Female
;
Fibroma
;
Lutein
;
Ovary
;
Thecoma
;
Biomarkers, Tumor
10.A case of ovarian sclerosing stromal tumor with massive ascites and elevated CA 125.
Hae Chang LEE ; Byoung Ryun KIM ; Jun Seok LEE ; Beob In LIM ; Heung Gon KIM ; Hyung Bae MOON ; Hoon Young KIM
Korean Journal of Obstetrics and Gynecology 2009;52(1):120-124
Sclerosing stromal tumor (SST) is an uncommon benign tumor of the ovary, representing 2~6% of all stromal ovarian tumors. It is a distinct benign neoplasm that differs from fibromas, thecomas, luteinized tumors and steroid cell tumors. It presents most often with non-specific symptoms and tumor markers usually remain normal. However massive ascites is a rare symptom. We report a case of sclerosing stromal tumor with massive ascites and elevated CA 125 with brief review of literature.
Ascites
;
Female
;
Fibroma
;
Lutein
;
Ovary
;
Thecoma
;
Biomarkers, Tumor